Riskpilot← Back to searchSign inGet full accessJuraMed A/S
A/SActiveCVR 41885491Leonorevej 6Activities of collection agencies and credit bureaus · NACE 8291Est. 20201 employees
Revenue 2024
DKK 38K
-28% vs 2023
EBITDA margin
-13.3%
-170% vs 2023
Equity ratio
65.9%
Financial strength
Net profit 2024
DKK -4K
-158% vs 2023
| Revenue | DKK 38K | -28% |
| EBITDA | DKK -5K | -170% |
| Net profit | DKK -4K | -158% |
| Total assets | DKK 458K | -47% |
| Equity | DKK 302K | -1% |
| Employees | 1 | — |
Legal name
JuraMed A/S
CVR number
41885491
Legal form
Aktieselskab
NACE code
8291 · Activities of collection agencies and credit bureaus
Founded
24. november 2020
Share capital
DKK 605.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør og bestyrelsesformanden i forening.
Company purpose
Selskabets formål er levering af serviceydelser i forbindelse med patienterstatningssager samt at hjælpe patienter med at inddrive kompensation, godtgørelse og erstatning fra regioner, hospitaler, læger osv. og dertil relateret virksomhed, og anden virksomhed besluttet af ledelsen.
Address
Leonorevej 6
Phone
+4531317259
Email
pt@juramed.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | -297 | -146 | 53 | 38 |
| Staff expenses | -0 | -23 | -45 | -43 |
| EBITDA | -297 | -169 | 7 | -5 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | -297 | -169 | 7 | -5 |
| Net financials | -2 | 98 | 0 | 1 |
| Profit before tax | -299 | -70 | 7 | -4 |
| Tax | -63 | -0 | -0 | -0 |
| Net profit | -236 | -70 | 7 | -4 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 241 | 310 | 858 | 458 |
| Equity | 169 | 299 | 306 | 302 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 72 | 11 | 552 | 156 |
| Total debt | 72 | 11 | 552 | 156 |
EBITDA margin
-13.3%
This company
15.8%
Market median
-184% vs market
20212024
Equity ratio
65.9%
This company
38.2%
Market median
+73% vs market
20212024
Return on equity
-1.4%
This company
18.4%
Market median
-108% vs market
20212024
Net profit margin
-11.0%
This company
8.1%
Market median
-236% vs market
20212024
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
20212024
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-11-24 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
AT Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PT HOLDING AF 27/6 ApS | Company | 50.0% | 50.0% | 2022 |
AJL Invest ApS | Company | 50.0% | 50.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ASH INVEST 4/17 ApS
JuraMed A/S Board members of JuraMed A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Hansen | Chief Executive Officer | 0 companies |
| Ann-Maj Thorgaard | Chief Executive Officer | 0 companies |
| Lucas Søholm Hansen | Board of Directors | 0 companies |
| Adam Søholm Hansen | Chairman | 0 companies |
| Uffe Brunø Lindstrøm | Board of Directors | 0 companies |
| Per Thorgaard | Board of Directors | 0 companies |